News Snapshot:
China is treating tens of thousands of its citizens with experimental coronavirus vaccines that have not had completed standard testing — raising concerns about safety. In July, China launched a vaccine emergency use program offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and biopharmaceutical company Sinovac Biotech. The vaccines were aimed to protect essential workers, including those in the medical field, transportation industry and grocery store workers. But now, China National Biotec Group — the Sinopharm unit developing two of the emergency use vaccines — and Sinovac Biotech have confirmed that...
